New report out on future medical innovation

Omnia Health, a US-based global community of some 548,000 healthcare professionals, has published a report on topics related to the future of innovations in health, including AI in healthcare and how the industry is investing in technology. Interviews with industry leaders predict the future of medical innovation in the report.

The future of healthcare is being led by innovative new medical devices and solutions. Leaders from across the Americas met at Florida International Medical Expo (FIME) to discuss what this innovation will look like, and what it means for healthcare organizations. The report was produced by Omnia Health and FIME with support from Medline and provides the following main conclusions:

  • In healthcare, AI is not going to replace anyone, but those who embrace it will be better than those who reject it
  • We invest in healthcare innovation through research, contracts, grants, and clinical trials
  • Local industry growth depends on public-private partnerships

Related News

Willum Þór: The question remains if our healthcare system is sustainable

On January 1st, Iceland took over the Presidency of the Nordic Council of Ministers. This intergovernmental organisation plays an important role in promoting innovations, health data integration, and cooperation between all major stakeholders in the Nordic healthcare. The Icelandic Health Minister elaborates on his vision to future health in the Nordic region, the Nordic strengths, Iceland’s plans for the Presidency with regards to health innovations, and the coming collaboration with Copenhagen Institute for Futures Studies

CIFS ran an all-day session at the Week of Health and Innovation (WHINN) in Odense

Copenhagen Institute for Futures Studies ran an all-day session at the annual Week of Health and Innovation (WHINN) in Odense, Denmark. CIFS’ program attracted over 40 experts from health and data organisations. We presented strategic foresight and futures studies in the health sector, concepts that are used to reimagine the future of the health sector, such as the Humanome and decentralised clinical trials. Also, we had a panel discussion on the newly started Phase V project on decentralised clinical trials, where CIFS is a contributing partner

Mergers and acquisitions in digital health on the rise again

A new report by Rock Health describes mergers and acquisitions as a new way to invest in digital health. It takes place despite a significant slowdown in digital health investments. The following are key merger and acquisition trends in digital health: Mergers and acquisitions in the digital health sector averaged nearly 23 deals per month in 2021, for a total of 273 transactions. A monthly average of 23 digital health mergers and acquisitions was recorded in January and February of 2022. During the second quarter of 2022, economic headwinds caused digital health mergers and acquisitions to decline to 13 deals per month. With an average of 15 deals per month in the third quarter of 2022, there have been 144 digital health mergers and acquisitions in the first three quarters of 2022. The report expects this trend to continue into the fourth quarter of 2022, with merger and acquisition deals continuing to increase.  Rock Health’s latest report identifies four archetypes of digital health buyers capitalizing on sell-side interests to meet the following operational needs: 1. Consolidation for inorganic growth: ‘As some digital health startups contemplate exiting the private market to avoid an austere funding climate, others are looking to weather the market by acquiring their competitors, leading to waves of sector consolidation. From the buyer’s perspective, consolidation is a useful approach to grow one’s customer base and build confidence from investors looking for growth indicators.’ 2. Acquisitions to enhance core operations and internal efficiencies ‘The second acquisition strategy involves purchasing digital health startups that enhance or streamline the acquirer’s core operations, ideally offsetting the cost of acquisition with the bottom-line savings that would result from new internal efficiencies. Interestingly, many acquirers pursuing this type of M&A approach are provider organizations, which are battling staffing cost surges and rollbacks in post-pandemic relief funding.’ 3. “Buy and build” deals for category expansion ‘ A third acquisition strategy involves buying digital health companies with features complementary to the acquirer entity—empowering the acquirer to move more freely upstream or downstream in the care delivery value chain. This stepwise strategy can help acquirers capture market share in adjacent care categories.’ 4. M&A for disruptive innovation ‘As interest rates have continued to soar, the relative cost of capital has increased in tandem. With the days of easy money in the rear-view mirror, Rock Health hypothesize that the players best positioned to make headline-grabbing M&A deals are primarily those who used the heady times of 2021 to accumulate and hold serious cash reserves.’

All News

Willum Þór: The question remains if our healthcare system is sustainable

On January 1st, Iceland took over the Presidency of the Nordic Council of Ministers. This intergovernmental organisation plays an important role in promoting innovations, health data integration, and cooperation between all major stakeholders in the Nordic healthcare. The Icelandic Health Minister elaborates on his vision to future health in the Nordic region, the Nordic strengths, Iceland’s plans for the Presidency with regards to health innovations, and the coming collaboration with Copenhagen Institute for Futures Studies

CIFS ran an all-day session at the Week of Health and Innovation (WHINN) in Odense

Copenhagen Institute for Futures Studies ran an all-day session at the annual Week of Health and Innovation (WHINN) in Odense, Denmark. CIFS’ program attracted over 40 experts from health and data organisations. We presented strategic foresight and futures studies in the health sector, concepts that are used to reimagine the future of the health sector, such as the Humanome and decentralised clinical trials. Also, we had a panel discussion on the newly started Phase V project on decentralised clinical trials, where CIFS is a contributing partner

New HIMSS book out on blockchain in healthcare

The HIMSS Series has a new book on blockchain in healthcare. “Blockchain in Healthcare: Innovations that Empower Patients, Connect Professionals, and Improve Care” is the title of the book. According to the book’s authors, Vikram Dhillon, John Bass, Max Hooper, David Metcalf, and Alex Cahana, blockchain technology may hold the greatest potential in healthcare. Some of the first use cases in medical payments, electronic health records, HIPAA/data privacy, and drug counterfeiting have been explored by early pioneers. There is still much work to be done in order to automate the complexities of today’s healthcare systems and design new systems that are focused on trust, transparency, and aligning incentives. In this book, Metcalf, Bass, Hooper, Cahana, and Dhillon have assembled over 50 contributors, including early adopters, thought leaders, and health innovators. They tell their stories and share their knowledge. The videos and transcripts provided by many authors and contributors humanize the technical details and abstract aspects of blockchain. Using the fundamentals of blockchain, the authors curated a collection of future-oriented examples that build on early successes. After a brief introduction to the fundamentals and the protocols available, as well as early blockchain efforts specific to health and healthcare, the authors discuss the promise of smart contracts and protocols to automate complex, distributed processes and some of the early consortiums that are exploring the possibilities. Throughout the book are examples and use cases, with special attention given to the more advanced and far-reaching examples that can be scaled at an industry-level. In addition, a discussion of integrating blockchain technology into other advanced healthcare trends and IT systems – such as telemedicine, artificial intelligence, the Internet of Things, value-based payments, patient engagement solutions, big data solutions, medical tourism, and clinical trials among many others – is presented. The final section provides a glimpse into the future using blockchain technology and examples of research projects that are still in labs across the globe.